コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nd is not dependent on the central regulator microphthalmia-associated transcription factor.
2 AMP response element-binding protein and the microphthalmia-associated transcription factor.
3 in copper status affected the expression of microphthalmia-associated transcription factor, a transc
4 through beta-catenin-mediated regulation of microphthalmia-associated transcription factor activity,
7 c acid, lipoic acid, and resveratrol reduced microphthalmia-associated transcription factor and tyros
8 ss the protein and mRNA expression levels of microphthalmia-associated transcription factor and tyros
10 ompanied by increased transcription of MITF (microphthalmia-associated transcription factor) and tyro
11 in and immunohistochemical markers (melan-A, microphthalmia-associated transcription factor, and SRY-
12 e supporting the concept that the effects on microphthalmia-associated transcription factor are depen
13 tified the melanocyte master regulator MITF (microphthalmia-associated transcription factor) as the t
14 Human MITF is, by convention, called the "microphthalmia-associated transcription factor" because
15 ult and neonatal melanocytes, SOX9 regulates microphthalmia-associated transcription factor, dopachro
16 ression of the melanocyte determining factor microphthalmia-associated transcription factor, elevated
18 functions by initially stimulating levels of microphthalmia-associated transcription factor expressio
19 Changes in endogenous microphthalmia-associated transcription factor expressio
20 Our findings suggest that modulation of microphthalmia-associated transcription factor expressio
21 ETV1 overexpression elevated microphthalmia-associated transcription factor expressio
22 t pathological group of tumours described as microphthalmia-associated transcription factor family tr
24 cultures, cAMP-induced transcription of the microphthalmia-associated transcription factor gene (Mit
25 in traditional Chinese medicine, upregulated microphthalmia-associated transcription factor gene expr
27 tion and further confirm the central role of microphthalmia-associated transcription factor in melano
30 noma and inversely correlates with FOXO3 and microphthalmia-associated transcription factor levels.
31 ytes via activation of melanocyte-restricted microphthalmia-associated transcription factor (M-MITF)
32 igration and survival by directly repressing microphthalmia-associated transcription factor-M and FOX
33 FOXO3, whereas enhanced expression of either microphthalmia-associated transcription factor-M or FOXO
34 duced by a DGK inhibitor, but tyrosinase and microphthalmia-associated transcription factor messenger
37 ced tanning response, we show that while the microphthalmia-associated transcription factor Mitf regu
38 h tooth shape; one region contained the gene microphthalmia-associated transcription factor Mitf that
39 g melanoma as a model, we show here that the microphthalmia-associated transcription factor MITF, a l
40 irection to the nucleus to interact with the microphthalmia associated transcription factor (MITF).
43 ng components of Wnt/beta-catenin signaling, Microphthalmia-Associated Transcription Factor (MITF) an
44 ility to potently downregulate expression of microphthalmia-associated transcription factor (MITF) an
45 xpression in the RPE of transgenic mice, and microphthalmia-associated transcription factor (MITF) an
47 ent pivotal signalling pathways (mediated by microphthalmia-associated transcription factor (MITF) an
48 gulation of two important signaling factors, microphthalmia-associated transcription factor (MITF) an
50 enetic and chemical approach to identify the microphthalmia-associated transcription factor (MITF) as
51 ific expression in the eye, and we suggested microphthalmia-associated transcription factor (MITF) as
52 expression of the lineage survival oncogene microphthalmia-associated transcription factor (MITF) co
55 g mediator of cell death (BIM) induction and microphthalmia-associated transcription factor (MITF) do
58 ntly a candidate approach was used to select microphthalmia-associated transcription factor (MITF) fo
59 e Type 2 is caused by mutations in the human Microphthalmia-associated transcription factor (MITF) ge
60 otic gene 3 (PAX3) is a key regulator of the microphthalmia-associated transcription factor (Mitf) in
61 regulation of the lineage addiction oncogene microphthalmia-associated transcription factor (MITF) is
67 ing and genomic sequencing, we find that the microphthalmia-associated transcription factor (MITF) is
79 , we show that the lineage survival oncogene microphthalmia-associated transcription factor (MITF) is
84 ), developmental and oncogenic roles for the microphthalmia-associated transcription factor (MITF) pa
87 reveals that the melanocyte master regulator microphthalmia-associated transcription factor (MITF) pr
90 s overexpressing the teneurin-1 ICD, several microphthalmia-associated transcription factor (MITF) ta
91 oma models, demonstrates the key role of the microphthalmia-associated transcription factor (MITF) th
92 ites of genes coding melanophilin (MLPH) and microphthalmia-associated transcription factor (MITF) th
93 In the 25 yr since the gene encoding the microphthalmia-associated transcription factor (MITF) wa
94 PROM1); ribosomal protein L13A (RPL13A); and microphthalmia-associated transcription factor (MITF) we
95 tfa gene encodes a zebrafish ortholog of the microphthalmia-associated transcription factor (Mitf) wh
96 munohistochemical stains for MART-1, HMB-45, microphthalmia-associated transcription factor (MiTF), a
97 at results in a decrease in beta-catenin and microphthalmia-associated transcription factor (MITF), a
98 fenib resistance correlated with the loss of microphthalmia-associated transcription factor (MITF), a
99 the nucleus, thereby reducing expression of microphthalmia-associated transcription factor (MITF), a
100 ding a key regulator of RPE gene expression, microphthalmia-associated transcription factor (MITF), c
102 We found that the transcription factor, microphthalmia-associated transcription factor (MITF), i
103 phosphorylation of p38 MAPK, which activates microphthalmia-associated transcription factor (MITF), k
104 downregulated B-catenin, B-catenin-regulated microphthalmia-associated transcription factor (MITF), s
105 gulated beta-catenin, beta-catenin-regulated microphthalmia-associated transcription factor (MITF), s
106 ation in the COPA gene and a mutation in the microphthalmia-associated transcription factor (MITF), t
107 n is associated with increased expression of microphthalmia-associated transcription factor (Mitf), w
109 sed invasion and, often, decreased levels of microphthalmia-associated transcription factor (MITF).
110 -211, a known target of the master regulator microphthalmia-associated transcription factor (MITF).
111 nin formation in melanocytes by inducing the microphthalmia-associated transcription factor (MITF).
112 ssion of mast cell-specifying genes Hes1 and microphthalmia-associated transcription factor (Mitf).
113 6) in the melanoma-lineage-specific oncogene microphthalmia-associated transcription factor (MITF).
114 tive stress results in reduced expression of microphthalmia-associated transcription factor (MITF).
115 reas via the suppression of beta-catenin and microphthalmia-associated transcription factor (MITF).
116 oximately 6 microm) with their substrate the microphthalmia-associated transcription factor (MITF).
117 for the expression of the RPE key regulator microphthalmia-associated transcription factor (Mitf); h
118 blue) and immunohistochemical probes (S-100, microphthalmia-associated transcription factor [MiTF], H
119 In vivo Brn-2 represses expression of the microphthalmia-associated transcription factor, MITF, to
120 virus (SFFV) proviral integration 1 (PU.1), microphthalmia-associated transcription factor, NF-kappa
121 angiomyolipoma, immunohistochemistry showed microphthalmia-associated transcription factor nuclear l
122 promoter, we identified agents that modulate microphthalmia-associated transcription factor promoter
123 luciferase reporter construct driven by the microphthalmia-associated transcription factor promoter,
125 sphodiesterase 4D3 inhibitors, T-oligos, and microphthalmia-associated transcription factor regulator
126 ag GTPases bound and regulated activation of microphthalmia-associated transcription factor, suggesti
127 on of the master regulator of melanogenesis, microphthalmia-associated transcription factor, thus sti
129 he essential osteoclast transcription factor microphthalmia-associated transcription factor were incr
130 0, controls the expression of another, MITF (microphthalmia-associated transcription factor), which i
131 se that co-expressed SOX2 and either CK20 or microphthalmia-associated transcription factor, which ar
132 pment from the neural crest, SOX10 regulates microphthalmia-associated transcription factor, which co
133 se element-binding protein and expression of microphthalmia-associated transcription factor, which en